Manmohan Reddy Leleti

This inventor holds 72 USPTO granted patents and 24 published patent applications, plus 11 CIPO patents and 22 EPO patents, primarily in Cancer Therapeutics (CPC class C07D). Top assignees: Chemocentryx, Inc., Arcus Biosciences, Inc., Other. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manmohan Reddy Leleti. Retrieved from https://idiyas.com/inventor/manmohan-reddy-leleti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 72 (Patent Applications = 24)

% Patents Active = 100.0

CIPO Patents = 11 (Patent Applications = 13)

EPO Patents = 22 (Patent Applications = 42)

Average Co-Inventor Count = 8.3

ph-index = 10

Forward Citations = 376(Granted Patents)

Forward Citations (Not Self Cited) = 248(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Sunnyvale, CA (US) (2009 - 2016)
Cupertino, CA (US) (2012 - 2017)
San Jose, CA (US) (2017)
West San Jose, CA (US) (2018 - 2021)
Dublin, CA (US) (2019 - 2024)

Company Filing History:

Arcus Biosciences, Inc.

patents

2 out of 834,570

Other

patents

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

5'-Nucleotidase

Immune Enhancing Drugs

Thiazole Compounds

HIF-2α Inhibitors

AXL Inhibitors

Adenosine Antagonists

Chemokine Receptor Modulators

Cancer-Related Disorders

CD73 Inhibitors

Oxindole Compounds

Quinazoline Derivatives

Tetralin Compounds

72 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649751 - Inhibitors of HPK1 and methods of use thereof (2026-06-09),

2. 12630562 - Piperidylurea compounds and methods of use thereof (2026-05-19),

3. 12630526 - Processes for preparing aminopyrimidine compounds (2026-05-19),

4. 12459967 - Modulators of 5'-nucleotidase, ecto and the use thereof (2025-11-04),

5. 12433836 - Parenterally administered immune enhancing drugs (2025-10-07),

6. 12410170 - 2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds (2025-09-09),

7. 12384773 - Thiazole compounds and methods of use thereof (2025-08-12),

8. 12226425 - Inhibitors of ARG1 and/or ARG2 (2025-02-18),

9. 12195482 - Compounds as inhibitors of AXL (2025-01-14),

10. 12195447 - Azolopyrimidine for the treatment of cancer-related disorders (2025-01-14),

11. 12168023 - Inhibitors of adenosine 5'-nucleotidase (2024-12-17),

12. 12145901 - Process for preparing tetralin compounds (2024-11-19),

13. 12139475 - 2-oxindole compounds (2024-11-12),

14. 12103907 - Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha (2024-10-01),

15. 12071411 - Inhibitors of HIF-2α and methods of use thereof (2024-08-27),

Title: Inventor Manmohan Reddy Leleti

Introduction: Manmohan Reddy Leleti is a prolific inventor based in Dublin, CA (US) known for his groundbreaking innovations in various fields.

Latest Patents: Manmohan Reddy Leleti holds several patents in the areas of technology, healthcare, and renewable energy, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Leleti has worked with renowned companies and research institutions, contributing significantly to the advancement of cutting-edge technologies.

Collaborations: Throughout his career, Manmohan Reddy Leleti has collaborated with top universities, leading research institutions, and innovative companies to bring his inventions to life and make a lasting impact on society.

Conclusion: Manmohan Reddy Leleti's dedication to innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor in the field.

Profile summary based on public USPTO records.